ZNF587 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.602200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.035800E-01
Normal-vs-Stage2
9.590800E-01
Normal-vs-Stage3
2.783600E-01
Normal-vs-Stage4
2.680800E-01
Stage1-vs-Stage2
2.220600E-01
Stage1-vs-Stage3
6.151900E-02
Stage1-vs-Stage4
3.188400E-01
Stage2-vs-Stage3
1.171550E-01
Stage2-vs-Stage4
2.092800E-01
Stage3-vs-Stage4
5.794500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.421400E-01
Normal-vs-AfricanAmerican
9.146400E-01
Normal-vs-Asian
9.453200E-01
Caucasian-vs-AfricanAmerican
7.809400E-01
Caucasian-vs-Asian
7.743800E-01
AfricanAmerican-vs-Asian
9.599600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.909600E-01
Normal-vs-Female
9.600600E-01
Male-vs-Female
4.629000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.732600E-01
Normal-vs-Age(41-60Yrs)
6.910000E-01
Normal-vs-Age(61-80Yrs)
9.296400E-01
Normal-vs-Age(81-100Yrs)
7.275400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.831400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.278200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.953200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.787800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.370250E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.064000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.743600E-01
Normal-vs-Daily Drinker
6.603200E-01
Normal-vs-Weekly Drinker
7.084200E-01
Normal-vs-Occasional Drinker
6.740000E-01
Normal-vs-Social Drinker
6.248200E-01
Non Drinker-vs-Daily Drinker
6.829800E-01
Non Drinker-vs-Weekly Drinker
7.521800E-01
Non Drinker-vs-Occasional Drinker
2.628400E-01
Non Drinker-vs-Social Drinker
2.854800E-01
Daily Drinker-vs-Weekly Drinker
9.803800E-01
Daily Drinker-vs-Occasional Drinker
9.046500E-02
Daily Drinker-vs-Social Drinker
7.909600E-02
Weekly Drinker-vs-Occasional Drinker
1.588150E-01
Weekly Drinker-vs-Social Drinker
1.345410E-01
Occasional Drinker-vs-Social Drinker
9.628800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.166200E-01
Normal-vs-Grade 2
4.373800E-02
Normal-vs-Grade 3
3.696100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.031200E-01
Grade 1-vs-Grade 3
2.244800E-01
Grade 1-vs-Grade 4
1.166200E-01
Grade 2-vs-Grade 3
3.720000E-01
Grade 2-vs-Grade 4
4.373800E-02
Grade 3-vs-Grade 4
3.696100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.100200E-01
Normal-vs-NonDiabetic
9.275200E-01
Diabetic-vs-NonDiabetic
1.116780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.648600E-01
Normal-vs-NoPancreatitis
9.844600E-01
Pancreatitis-vs-NoPancreatitis
9.637600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.250800E-01
Normal-vs-N1
9.924200E-01
N0-vs-N1
7.318600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.818800E-01
Normal-vs-TP53-NonMutant
7.586800E-01
TP53-Mutant-vs-TP53-NonMutant
4.684200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
